Literature DB >> 12271278

Imiquimod: a cytokine inducer.

Mark V Dahl1.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12271278     DOI: 10.1067/mjd.2002.126586

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  13 in total

1.  Expression of Toll-like Receptor 2 in Cultured Human Keratinocytes: The Effect of Bacterial Antigens, Cytokines and Calcium Concentration.

Authors:  Bark-Lynn Lew; Woo-Young Sim; Nack-In Kim
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

2.  Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream.

Authors:  Na Hee Kim; Jee Bum Lee; Sook Jung Yun
Journal:  Ann Dermatol       Date:  2018-06-28       Impact factor: 1.444

Review 3.  [Standard and experimental therapy of cutaneous T-cell lymphoma].

Authors:  M Beyeler; R Dummer
Journal:  Hautarzt       Date:  2003-12       Impact factor: 0.751

4.  Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer.

Authors:  Hakim Echchannaoui; Matteo Bianchi; David Baud; Martine Bobst; Jean-Christophe Stehle; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

5.  [Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases].

Authors:  C Loquai; D Nashan; D Metze; U Beiteke; K W Rüping; T A Luger; S Grabbe
Journal:  Hautarzt       Date:  2004-02       Impact factor: 0.751

Review 6.  Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches.

Authors:  Zafer Sattouf; Steven J Repas; Jeffrey B Travers; Craig A Rohan
Journal:  J Skin Cancer       Date:  2021-06-19

7.  Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection.

Authors:  Monica C Panelli; Mitchell E Stashower; Herbert B Slade; Kina Smith; Christopher Norwood; Andrea Abati; Patricia Fetsch; Armando Filie; Shelley-Ann Walters; Calvin Astry; Eleonora Aricó; Yingdong Zhao; Silvia Selleri; Ena Wang; Francesco M Marincola
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

8.  Induction of Vitiligo-Like Hypopigmentation after Imiquimod Treatment of Extramammary Paget's Disease.

Authors:  Hyuck Hoon Kwon; Kwang Hyun Cho
Journal:  Ann Dermatol       Date:  2012-11-08       Impact factor: 1.444

9.  Vitamin D Receptor Expression in Vitiligo.

Authors:  Reham William Doss; Abdel-Aziz El-Rifaie; Yasser M Gohary; Laila A Rashed
Journal:  Indian J Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.494

10.  Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.

Authors:  Athina Angelopoulou; Nikos Alexandris; Evangelia Konstantinou; Konstantinos Mesiakaris; Charilaos Zanidis; Konstantinos Farsalinos; Konstantinos Poulas
Journal:  Environ Res       Date:  2020-06-23       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.